IRIS
RUSSO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.159
NA - Nord America 4.703
AS - Asia 4.031
SA - Sud America 1.081
AF - Africa 107
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.572
RU - Federazione Russa 2.976
SG - Singapore 2.180
BR - Brasile 918
CN - Cina 857
IE - Irlanda 750
IT - Italia 687
SE - Svezia 478
HK - Hong Kong 371
DE - Germania 304
PL - Polonia 222
FR - Francia 220
FI - Finlandia 196
VN - Vietnam 182
IN - India 130
GB - Regno Unito 95
UA - Ucraina 78
AR - Argentina 55
CA - Canada 51
MX - Messico 45
BD - Bangladesh 44
TR - Turchia 39
EC - Ecuador 33
ZA - Sudafrica 31
JP - Giappone 30
ID - Indonesia 29
NL - Olanda 29
AT - Austria 25
BE - Belgio 25
IQ - Iraq 23
MA - Marocco 23
CI - Costa d'Avorio 22
UZ - Uzbekistan 20
CO - Colombia 18
PK - Pakistan 18
ES - Italia 17
VE - Venezuela 17
CL - Cile 15
AZ - Azerbaigian 12
LT - Lituania 12
KE - Kenya 11
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
PY - Paraguay 9
SA - Arabia Saudita 9
AU - Australia 8
EU - Europa 8
PE - Perù 8
PH - Filippine 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
IL - Israele 7
NP - Nepal 7
JM - Giamaica 6
MY - Malesia 6
JO - Giordania 5
OM - Oman 5
PT - Portogallo 5
TH - Thailandia 5
BH - Bahrain 4
CH - Svizzera 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DM - Dominica 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
KR - Corea 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
GY - Guiana 1
KH - Cambogia 1
LU - Lussemburgo 1
Totale 16.093
Salva come PNG Salva come JPEG
Città #
Moscow 923
Ashburn 854
Singapore 799
Dublin 747
Chandler 540
Dallas 510
Hong Kong 371
Nyköping 321
Beijing 319
Warsaw 220
Messina 206
San Jose 201
Jacksonville 186
Munich 157
The Dalles 143
Princeton 128
Ann Arbor 121
Los Angeles 114
Lauterbourg 110
Medford 110
Helsinki 81
Des Moines 79
Cambridge 72
São Paulo 72
Ho Chi Minh City 69
Dearborn 67
New York 61
Buffalo 52
Tianjin 50
Boardman 48
Council Bluffs 48
Bremen 41
Wilmington 38
Redondo Beach 37
Orem 35
Turku 35
Jinan 32
Pune 31
Rio de Janeiro 30
Frankfurt am Main 28
Chennai 27
Tokyo 25
Houston 24
Santa Clara 23
Abidjan 22
Curitiba 22
Hanoi 22
Hyderabad 22
Rome 22
Shenyang 22
Brussels 21
Catania 20
Guangzhou 20
Seattle 20
Tashkent 19
Brasília 18
Johannesburg 18
Brooklyn 17
Mexico City 17
Nanjing 17
Nuremberg 17
Belo Horizonte 16
Woodbridge 16
Zhengzhou 16
Chicago 15
Hebei 15
Jakarta 15
San Mateo 15
Amsterdam 14
Campinas 14
Denver 14
Lappeenranta 14
London 14
Montreal 14
Ningbo 14
San Francisco 14
Milan 13
Porto Alegre 13
Shenzhen 13
Atlanta 12
Baku 12
Dong Ket 12
Duncan 12
Guayaquil 12
Lancaster 12
Palermo 12
Shanghai 12
Taizhou 12
Toronto 12
Changsha 11
Vienna 11
Baghdad 10
Hangzhou 10
Istanbul 10
Poplar 10
Quito 10
Redwood City 10
Ribeirão Preto 10
Salvador 10
Boston 9
Totale 9.011
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 362
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 326
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 284
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 255
Clinical and pathological features of focal myositis 248
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 240
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 239
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 230
A Nouvel serum MicroRNA signature to screen ATTR 225
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 210
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 197
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 190
Alexithymia, burden and resilience in ALS’ caregivers 189
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 180
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 175
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 174
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 173
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 173
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 168
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 168
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 168
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 165
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 164
Autoimmune juvenile limb-girdle myasthenia 164
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 163
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 161
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 158
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 158
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 157
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 156
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 156
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 155
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 154
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 153
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 152
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 152
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 150
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 148
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 147
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 146
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 144
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 143
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 141
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 140
La deformazione longitudinale e radiale del ventricolo sinistro è ridotta nell’amiloidosi cardiaca familiare: studio con ecocardiogramma bi-dimensionale e risonanza magnetica cardiaca. 138
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 136
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 135
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 135
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 130
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 127
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 126
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 126
Considerable post-partum worsening in a patient with CMT2E 125
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 125
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 124
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 123
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 121
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury 119
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 116
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 114
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 113
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 112
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 112
Miopatia prossimale in paziente con sindrome di Williams 106
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 106
Factors predicting survival in ALS: a multicenter Italian study 105
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 105
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 103
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 102
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 101
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 99
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 99
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 98
Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy 97
The THAOS: record of patients from our site. 95
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 94
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 91
Repurposing chemotherapy-induced peripheral neuropathy grading 89
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 89
Left atrial function in cardiac amyloidosis 88
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 88
Variable phenotypes are associated with PM22 missense mutations. 87
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: Secondary analysis of data from the CI-PeriNomS study 86
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 86
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 85
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 85
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 85
Correlation between morphologic and functional echocardiographic indexes and semiquantitative analysis of 99mTC-DPD scintigraphy in patients with transthyretin related amyloidosis 84
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 83
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 83
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 83
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 83
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 82
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers 82
Prominent distal lower limbs involvement with hyperreflexia in a family with seipin related axonal motorneuropathy. 82
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 81
Systematic investigation on needs and use of technological device in amyotrophic lateral sclerosis patients and caregivers: a natinwide, multicentre survey. 80
Totale 14.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 95 39 29
2021/2022759 19 89 5 30 49 11 74 41 26 50 59 306
2022/20232.033 165 185 110 149 158 169 20 94 912 7 43 21
2023/2024517 42 77 26 38 53 121 20 32 7 35 15 51
2024/20253.588 46 52 64 177 146 128 186 551 643 170 655 770
2025/20267.566 402 605 585 539 695 1.548 987 954 894 357 0 0
Totale 16.498